Reconstructing ancient climate provides clues to climate change
November 5, 2024New research from ϳԹ also challenges timing of Andes mountains uplift As the Earth faces unprecedented climate change, a look into the planet’s deep past may provide vital insights into what may lie ahead. Knowledge of the natural world millions of years ago is fragmented, but a 15-year study of a site in Bolivia by…Proposed scoring system may enhance equity in organ transplantation, increase transplant rates and improve patient survival
October 30, 2024The system, devised by researchers at ϳԹ and Cleveland Clinic, better accounts for biological disadvantages that limit access to transplant for some patients Researchers at ϳԹ and Cleveland Clinic have developed a new method that could potentially help provide better access to lung…‘What does this mean?’ How to interpret medical test results and advocate for your health
October 29, 2024With the rise of digital health tools and abundant online resources, we live in an era where healthcare information is more accessible than ever. This information is essential to navigate one’s health journey, but without an understanding of complex data and medical jargon, test results may prompt patients to wonder what it all means.Medicine’s Paul Tesar among three Faculty Distinguished Research Award winners who will be celebrated during ϳԹ’s Innovation Week
October 25, 2024Innovation Week, the annual celebration of ϳԹ’s innovative and entrepreneurial spirit, kicks off on Monday, Oct. 28. Among the festivities will be the honoring of this year’s Faculty Distinguished Research Award winners. Established in 2013, the award is given annually to faculty members who have made…Popular diabetes and weight-loss drug may reduce risk of Alzheimer’s disease
October 24, 2024Researchers at ϳԹ School of Medicine have found that, when compared to seven other anti-diabetic drugs, semaglutide, a popular diabetes and weight-loss drug, may lower the risk of Alzheimer’s disease in people with type 2 diabetes (T2D).ϳԹ awarded $2.6M to study impact of high blood-pressure medications on chronic kidney disease patients
October 22, 2024The National Institutes of Health awarded a four-year, $2.6 million grant to researchers at ϳԹ to study how high blood-pressure drugs affect patients with chronic kidney disease (CKD). More specifically, they want to study whether such medications increase the risk of kidney and cardiovascular…Researchers awarded $1.3M to help military veterans battling acute myeloid leukemia
October 15, 2024With a new four-year, $1.3 million grant from the U.S. Department of Veterans Affairs, researchers at ϳԹ are investigating a new approach to treat acute myeloid leukemia (AML) in military veterans.ϳԹ awarded $1.9M federal grant to develop technology to better understand genome data
October 8, 2024Research could lead to new discoveries in cancer medicine With a new five-year, $1.9 million grant from the National Institute of General Medical Sciences (NIGMS), researchers at ϳԹ will develop computer software to analyze and interpret complex genome data.Researchers at ϳԹ, Vanderbilt universities to develop incisionless prostate surgery using MRI and robotics
October 2, 2024Researchers awarded five-year, $3.7M grant from National Institutes of Health, National Cancer Institute Researchers at ϳԹ and Vanderbilt University are pioneering a new approach to prostate cancer surgery by combining advanced robotics and “low-field” MRI technology.Student Profile: Sajal Kulhari
September 30, 2024Class Year: 2025 Program: Doctor of MedicineResearchers close in on understanding possible cause of Alzheimer’s disease
September 30, 2024Awarded four-year, $3.3M grant from National Institutes of Health With a four-year, $3.3 million grant from the National Institutes of Health (NIH), researchers from ϳԹ will study whether certain brain proteins may play a role in the development of Alzheimer’s disease.Research team launches first-of-its-kind study that could significantly impact clinical care for opioid-exposed infants at risk for developmental delays
September 27, 2024With a $3 million grant from the NIH, experts are using advanced imaging technology to better understand changes in the infant brain that may accompany Neonatal Abstinence Syndrome Magnetic resonance fingerprinting (MRF), first described in the journal Nature in 2013 by engineers at ϳԹ School of Medicine and…Popular diabetes and weight-loss drug associated with lower opioid overdose risk
September 25, 2024Since being deemed a public health emergency in 2017, opioids are responsible for 72% of drug overdose deaths in the United States, according to the National Center for Drug Abuse Statistics. New research from ϳԹ School of Medicine identifies a potential new approach to address the opioid overdose…Learn more about Adrianne Crawford Fletcher, vice dean, diversity, equity and inclusive excellence for the School of Medicine
September 23, 2024When Adrianne Crawford Fletcher, vice dean, diversity, equity and inclusive excellence for the School of Medicine, reflects on her passion for this work, she starts with the importance of building strong relationships and being thoughtful and open without making assumptions.ϳԹ team plays a key role in cystic fibrosis research
September 17, 2024When it comes to diseases such as cystic fibrosis (CF), gene editing—a process that alters the biological properties of cells—can be fundamental in driving treatment. But as promising as it is in lab settings, effectively reaching patients’ lung cells with such treatments has been challenging. The hurdle is so pervasive in therapeutic gene…